by Qube | Mar 10, 2019 | Uncategorized
QUBE welcomes VB Devices to the Technology Park. VB devices is a start-up dedicated to the development of two medical devices for use in surgery. Purespume, now in industrialisation phase is a medical device targeted for use by vascular surgeons for the treatment of...
by Qube | Feb 1, 2019 | Uncategorized
Sylentis a company fo the PharmaMar group with offices and laboratories at QUBE announces results of its Phase III Clinical Trial HELIX with tivanisiran (SYL1001) for the treatment of Dry Eye Syndrome. The HELIX trial has demonstrated an improvement (p=0.035) in the...
by Qube | Jan 12, 2019 | Uncategorized
Agrenvec, a company based at QUBE, broadens its portfolio of policlonal antibodies and recombinant proteins expressed in plants. Agreenvec is focused in the expression and purificacion of recombinant proteins in plants. Expresion in plants allows……..
